Differences in PTX3 expression were observed between deteriorating and recovering COVID-19 patients, with associated changes in the JAK-STAT, NF-κB, and MAPK signaling pathways, all contributing to inflammatory responses (89). Here, PTX3 is linked to COVID-19.